Caplin Point Laboratories Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

Particulars	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26
Revenue	502	510	534	543	600
Other income	26	23	30	34	28
Segment revenue (incl. inter-segment)	528	533	564	576	629
Expenses	352	349	363	373	415
Cost of materials consumed	61	74	92	89	102
Purchases of stock-in-trade	139	114	122	128	209
Change in inventories	2	8	-4	-2	-66
Employee benefit expense	47	43	47	50	53
Finance costs	0.20	0.20	0.20	0.20	0.40
Depreciation & amortisation	17	16	18	19	19
Other expenses	87	94	87	88	98
EBITDA	194	201	220	224	232
EBIT	177	184	201	204	213
Operating profit	151	184	201	204	213
Profit Before Tax	177	184	201	204	213
Tax expense	31	34	41	38	41
Deferred tax	2	0.60	4	2	-0.50
Net Profit	145	151	160	166	173
Financial Ratios
Operating Profit Margin	30.08%	36.08%	37.64%	37.57%	35.50%
EBITDA Margin	38.69%	39.31%	41.12%	41.16%	38.70%
Net Profit Margin	28.88%	29.61%	29.96%	30.57%	28.83%
Earnings Per Share (₹)	18.75	20.10	20.32	21.56	22.38

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.